熱門資訊> 正文

催化剂制药公司2026年第一季度盈利预览

2026-05-11 05:35

催化劑製藥(CPRX) 0

Catalyst Pharmaceuticals, Inc. (CPRX) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
The consensus EPS Estimate is $0.64 (-5.9% Y/Y) and the consensus Revenue Estimate is $148.18M (+5.1% Y/Y).
Over the last 2 years, CPRX has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 2 downward.

More on Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful Overhang
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript
Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1B
Catalyst Pharmaceuticals jumps on report of interest from Angelini Pharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。